A bioprinted periosteum organoid enables functional repair of critical-sized bone defects.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42491381.
- Also identified by DOI 10.1016/j.bioactmat.2026.05.043 and PMC identifier 13377428.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The periosteum is an essential yet often neglected regulator of bone regeneration, and its loss represents a major barrier to healing critical-sized bone defects. Existing periosteum-mimicking strategies rely primarily on static architectures or exogenous factor delivery and fail to reconstruct a living periosteal interface. Here, we introduce an organoid-based approach for engineering functional periosteum organoids capable of restoring periosteal identity and regulatory function. A bioprinted GelMA/SilMA interpenetrating composite hydrogel integrated with black phosphorus nanosheets is developed to create a mechanically stable and bioactive microenvironment that supports osteogenic-angiogenic self-organization. Under three-dimensional culture, the constructs exhibit the potential to form periosteum organoids, with coordinated osteogenic differentiation and pro-angiogenic niche formation. Following <i>in vivo</i> conditioning, the constructs develop into periosteum organoids that exhibit dense collagen-rich fibrous architecture, pronounced periostin expression, enrichment of osteogenic lineage cells, and stabilized microvasculature, closely recapitulating the structural and functional hallmarks of native periosteum. When applied to a critical-sized rat calvarial defect model, the periosteum organoids significantly enhance bone regeneration, improve trabecular microarchitecture, reconstruct a functional periosteal interface, and rebalance bone remodeling without detectable systemic toxicity. This work establishes periosteum organoids as a living regenerative interface for skeletal repair and provides a new organoid-based paradigm for functional periosteal reconstruction in large bone defects.